American Heart Association In Brief: Cardiovascular Dynamics
This article was originally published in The Gray Sheet
Executive Summary
Cardiovascular Dynamics: Launches its ARC (Active Response Catheter) and Lynx F/X catheters at the AHA scientific sessions. The ARC device, approved by FDA in June, incorporates CVD Focus technology to "provide a versatile device that can perform interventional coronary procedures using both low and high balloon inflation pressures on a single catheter," CVD says. Shipments are slated to begin by the end of 1996. The Lynx F/X catheters, launched at AHA to European and Japanese physicians, feature a smaller catheter shaft and a reduced balloon profile than its previous devices. The Lynx device also features CVD's extended-pressure Focus balloon technology, which allows the product to be used in procedures "requiring moderate and high pressure dilatation." The Lynx F/X will not be launched in the U.S. due to patent restrictions regarding its rail design; however, the firm expects an over-the-wire version to be available in early 1997 following FDA PMA supplement approval...
You may also be interested in...
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.